Doxorubicin Accord 2 mg/ml koncentrat till infusionsvätska

DRUG2 trials

Sponsors

Karolinska Institutet, Uppsala University Hospital

Conditions

Breast cancer female NOSColorectal cancer with peritoneal metastases

Phase 2

COLOVERT – Conversion therapy in colorectal cancer with peritoneal metastases not amenable to upfront cytoreductive surgery and HIPEC: a phase II “pick-the-winner” open-label randomized trial

Not yet recruitingCTIS2026-526122-41-00

Uppsala University HospitalColorectal cancer with peritoneal metastases

Target: 60Updated: 2026-07-15

Phase 4

TailorDose®-II: Therapeutic dose monitoring of commonly used cytostatic drugs/regimes indicated for breast cancer

Not yet recruitingCTIS2024-514818-12-00

Karolinska InstitutetBreast cancer female NOS

Target: 200Updated: 2025-11-13

Related Papers

Method-Comparison Validation of a Novel Capillary Blood Collection Kit, True Dose® TD-EPI, for Therapeutic Drug Monitoring of Epirubicin

Pharmaceuticals2026-01-28

Development and evaluation of a novel capillary blood collection method for decentralized therapeutic drug monitoring using the True Dose kit.

2025-09-29

Capillary Blood Self-Sampling for Therapeutic Drug Monitoring: A Mixed-Methods Usability Study of the True Dose<sup>®</sup> Kit.

2025-07-09